| |
 |
|
Class Information
Number: 514/178
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Cyclopentanohydrophenanthrene ring system doai > Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system > Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system
Description: Subject matter wherein one nuclear carbon of the cyclopentanohydrophenanthrene nucleus is bonded to an oxygen through a double bond and wherein another nuclear carbon atom of said cyclopentanohydrophenanthrene is bonded to at least one other oxygen through a single bond as, e.g., ether, hydroxy or alcoholate, etc.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5972922 |
Steroids which inhibit angiogenesis |
Oct. 26, 1999 |
| 5968918 |
Method for the prevention of coronary artery spasm |
Oct. 19, 1999 |
| 5968917 |
Composition containing diosgenin |
Oct. 19, 1999 |
| 5965550 |
Process for the preparation of 4-amino-.DELTA..sup.4 -3-ketosteroids via 4-nitro-.DELTA..sup.4 -3-ketosteroids |
Oct. 12, 1999 |
| 5962443 |
19-nur-pregnane steroids as neurochemical initiators of change in human hypothalamic function |
Oct. 5, 1999 |
| 5955455 |
Therapeutic methods and delivery systems utilizing sex steroid precursors |
Sep. 21, 1999 |
| 5955454 |
Nasal pharmaceutical composition containing a progestogen |
Sep. 21, 1999 |
| 5955439 |
Pharmaceutical aerosol containing at least one sugar |
Sep. 21, 1999 |
| 5935949 |
Use of androgen therapy in fibromyalgia and chronic fatigue syndrome |
Aug. 10, 1999 |
| 5929060 |
Method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue |
Jul. 27, 1999 |
| 5929061 |
Method for treating vascular headaches |
Jul. 27, 1999 |
| 5922700 |
Therapeutic methods and delivery systems utilizing sex steroid precursors |
Jul. 13, 1999 |
| 5922701 |
Method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue |
Jul. 13, 1999 |
| 5919465 |
Methods for augmenting immunological responses through the administration of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) |
Jul. 6, 1999 |
| 5914324 |
6-Hydroxy and 6-oxo-androstane derivatives active on the cardiovascular system and pharmaceutical compositions containing same |
Jun. 22, 1999 |
| 5910493 |
Hormonal agent for skin treatment |
Jun. 8, 1999 |
| 5906987 |
Treatment of male climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with androgens and/or aromatase inhibitors |
May. 25, 1999 |
| 5898032 |
Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
Apr. 27, 1999 |
| 5895783 |
Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor |
Apr. 20, 1999 |
| 5891868 |
Methods for treating postmenopausal women using ultra-low doses of estrogen |
Apr. 6, 1999 |
| 5888996 |
Inhibition of NMDA receptor activity and modulation of glutamate-mediated synaptic activity |
Mar. 30, 1999 |
| 5885977 |
Use of .DELTA.5 androstenes in the treatment of HIV wasting syndrome |
Mar. 23, 1999 |
| 5885978 |
External therapeutic composition for dermatitis |
Mar. 23, 1999 |
| 5880117 |
Use of 4-androstenediol to increase testosterone levels in humans |
Mar. 9, 1999 |
| 5879711 |
Stable antiandrogenic gel composition |
Mar. 9, 1999 |
| 5880116 |
Use of celastrol to treat alzheimer's disease |
Mar. 9, 1999 |
| 5877212 |
Molecular complex and control-release of alpha hydroxyacids |
Mar. 2, 1999 |
| 5872114 |
Therapeutic methods and delivery systems utilizing sex steroid precursors |
Feb. 16, 1999 |
| 5869475 |
Certain 3-ketosteroids used to inhibit steroid 5.alpha.-reductase |
Feb. 9, 1999 |
| 5861391 |
Use of dehydroepiandrosterone to treat primary adrenal insufficiency and Addison's disease |
Jan. 19, 1999 |
| 5861390 |
Steroid sulphatase inhibitors |
Jan. 19, 1999 |
| 5861389 |
Methods of treating androgen deficiency in men using selective aromatase inhibitors |
Jan. 19, 1999 |
| 5859000 |
Method for reducing mast cell mediated allergic reactions |
Jan. 12, 1999 |
| 5856299 |
Highly reactive esters of carboxy polysaccharides and carboxy polysaccharides derived therefrom |
Jan. 5, 1999 |
| 5855920 |
Total hormone replacement therapy |
Jan. 5, 1999 |
| 5854230 |
Antiandrogenic agents and related pharmaceutical compositions and methods of use |
Dec. 29, 1998 |
| 5849740 |
Methods for using ketoconazole and related substances in medicaments for treatment of type II diabetes |
Dec. 15, 1998 |
| 5849729 |
Use of hydrolyzed cocoa butter for percutaneous absorption |
Dec. 15, 1998 |
| 5846963 |
Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
Dec. 8, 1998 |
| 5846962 |
Anti-obesity agents |
Dec. 8, 1998 |
| 5843932 |
Therapeutic methods and delivery systems utilizing sex steroid precursors |
Dec. 1, 1998 |
| 5837269 |
Vaccine compositions and method for enhancing an immune response |
Nov. 17, 1998 |
| 5837698 |
Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs |
Nov. 17, 1998 |
| 5837700 |
Therapeutic methods and delivery systems utilizing sex steroid precursors |
Nov. 17, 1998 |
| 5834452 |
1- or 6-hydroxylated steroids |
Nov. 10, 1998 |
| 5834451 |
Remedy for myotonic dystrophy |
Nov. 10, 1998 |
| 5830886 |
Steroid sulphatase inhibitors |
Nov. 3, 1998 |
| 5827841 |
Method for enhancement of production of lymphokines and applications thereof |
Oct. 27, 1998 |
| 5824671 |
Therapeutic methods and delivery systems utilizing sex steroid precursors |
Oct. 20, 1998 |
| 5824670 |
17-deoxycorticosteroid-21-[O]carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds |
Oct. 20, 1998 |
|
|
|
